{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:30:28Z","timestamp":1790094628286,"version":"4.0.1"},"reference-count":470,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.imbio.2022.152279","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T06:58:56Z","timestamp":1663138736000},"page":"152279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Innate and adaptive immune responses against Influenza A Virus: Immune evasion and vaccination strategies"],"prefix":"10.1016","volume":"227","author":[{"given":"Praveen M.","family":"Varghese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Rajkumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2022.152279_bib1618","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fmicb.2017.01117","article-title":"Complement Evasion Strategies of Viruses: An Overview","volume":"8","author":"Agrawal","year":"2017","journal-title":"Frontiers in microbiology"},{"issue":"6","key":"10.1016\/j.imbio.2022.152279_bib1619","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/vim.2017.0022","article-title":"Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate","volume":"30","author":"Ainai","year":"2017","journal-title":"Viral immunology"},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1777","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/1348-0421.12775","article-title":"Human immune responses elicited by an intranasal inactivated H5 influenza vaccine","volume":"64","author":"Ainai","year":"2020","journal-title":"Microbiology and immunology"},{"key":"10.1016\/j.imbio.2022.152279_b0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(02)00228-6","article-title":"Recognition of pathogen-associated molecular patterns by TLR family","volume":"85","author":"Akira","year":"2003","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imbio.2022.152279_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01586","article-title":"Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D","volume":"9","author":"Al-Ahdal","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2022.152279_b0020","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.immuni.2011.03.026","article-title":"NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-\u03baB Signaling Pathways","volume":"34","author":"Allen","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2022.152279_b0025","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1042\/CS20160259","article-title":"Pulmonary immunity to viruses","volume":"131","author":"Allie","year":"2017","journal-title":"Clin. Sci."},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_b0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.imbio.2019.02.006","article-title":"Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity","volume":"224","author":"Al-Qahtani","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2022.152279_b0035","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.3389\/fimmu.2018.02379","article-title":"Pattern Recognition Receptors and the Host Cell Death Molecular Machinery","volume":"9","author":"Amarante-Mendes","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0040","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1073\/pnas.87.12.4485","article-title":"Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins","volume":"87","author":"Anders","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.imbio.2022.152279_b0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.0105-2896.2010.00909.x","article-title":"Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state","volume":"235","author":"Andrade","year":"2010","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.imbio.2022.152279_bib1621","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048322","article-title":"A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years","volume":"7","author":"Antrobus","year":"2012","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1620","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/mt.2013.162","article-title":"Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses","volume":"22","author":"Antrobus","year":"2014","journal-title":"Molecular therapy\u202f: the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.imbio.2022.152279_b0050","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1128\/MCB.20.17.6259-6268.2000","article-title":"Eukaryotic Translation Initiation Factor 4GI Is a Cellular Target for NS1 Protein, a Translational Activator of Influenza Virus","volume":"20","author":"Aragon","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.imbio.2022.152279_b0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-1759(96)00243-8","article-title":"Isolation and characterization of mouse nasal-associated lymphoid tissue","volume":"202","author":"Asanuma","year":"1997","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imbio.2022.152279_b0060","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1622","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1038\/s41467-018-04704-9","article-title":"A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA","volume":"9","author":"Bangaru","year":"2018","journal-title":"Nature communications"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_bib1616","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","article-title":"A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface","volume":"177","author":"Bangaru","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/infdis\/jiu094","article-title":"Influenza Virus Uses Its Neuraminidase Protein to Evade the Recognition of Two Activating NK Cell Receptors","volume":"210","author":"Bar-On","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"34","key":"10.1016\/j.imbio.2022.152279_bib1623","doi-asserted-by":"crossref","first-page":"14490","DOI":"10.1073\/pnas.0903477106","article-title":"Uncoupling CD21 and CD19 of the B-cell coreceptor","volume":"106","author":"Barrington","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"13","key":"10.1016\/j.imbio.2022.152279_b0070","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1002\/j.1460-2075.1994.tb06614.x","article-title":"Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent","volume":"13","author":"Baudin","year":"1994","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.imbio.2022.152279_b0075","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.imbio.2022.152279_bib1624","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3389\/fimmu.2018.02060","article-title":"Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections","volume":"9","author":"Bernasconi","year":"2018","journal-title":"Frontiers in immunology"},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1617","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S1369-5274(99)80066-6","article-title":"Initial and innate responses to viral infections--pattern setting in immunity or disease","volume":"2","author":"Biron","year":"1999","journal-title":"Current opinion in microbiology"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1625","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/v11020190","article-title":"Novel Approaches for The Development of Live Attenuated Influenza Vaccines","volume":"11","author":"Blanco-Lobo","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.imbio.2022.152279_b0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of Antigen Processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0090","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2165\/11537960-000000000-00000","article-title":"Drugs in Development for Influenza","volume":"70","author":"Boltz","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.imbio.2022.152279_b0095","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.imbio.2022.152279_b0100","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1073\/pnas.75.10.4886","article-title":"Globin mRNAs are primers for the transcription of influenza viral RNA in vitro","volume":"75","author":"Bouloy","year":"1978","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_b0105","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1128\/jvi.32.3.895-904.1979","article-title":"Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro","volume":"32","author":"Bouloy","year":"1979","journal-title":"J. Virol."},{"issue":"Suppl 4","key":"10.1016\/j.imbio.2022.152279_b0110","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152279_b0115","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0092-8674(92)90189-J","article-title":"Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface","volume":"68","author":"Brown","year":"1992","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.imbio.2022.152279_bib1626","doi-asserted-by":"crossref","first-page":"13724","DOI":"10.1074\/jbc.271.23.13724","article-title":"Site-directed mutagenesis of Cys-15 and Cys-20 of pulmonary surfactant protein D. Expression of a trimeric protein with altered anti-viral properties","volume":"271","author":"Brown-Augsburger","year":"1996","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.imbio.2022.152279_b0120","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1128\/JVI.07172-11","article-title":"Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin Mediate Protection against Lethal Influenza Virus Infection","volume":"86","author":"Brown","year":"2012","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_b0130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/jvi.36.2.586-590.1980","article-title":"Incorporation of influenza virus M-protein into liposomes","volume":"36","author":"Bucher","year":"1980","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nri2916","article-title":"Phenotypical and functional specialization of FOXP3+ regulatory T cells","volume":"11","author":"Campbell","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"26","key":"10.1016\/j.imbio.2022.152279_bib1627","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa0906612","article-title":"Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China","volume":"361","author":"Cao","year":"2009","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.imbio.2022.152279_b0140","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J. Immunol."},{"issue":"2 Pt 1","key":"10.1016\/j.imbio.2022.152279_bib1628","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0092-8674(82)90135-0","article-title":"The antigenic structure of the influenza virus A\/PR\/8\/34 hemagglutinin (H1 subtype)","volume":"31","author":"Caton","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0145","unstructured":"CDC, 2009. CDC Novel H1N1 Flu | The 2009 H1N1 Pandemic: Summary Highlights, April 2009-April 2010."},{"key":"10.1016\/j.imbio.2022.152279_b0160","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1093\/emboj\/18.8.2273","article-title":"Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery","volume":"18","author":"Chen","year":"1999","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.imbio.2022.152279_b0150","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nm1201-1306","article-title":"A novel influenza A virus mitochondrial protein that induces cell death","volume":"7","author":"Chen","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2022.152279_b0155","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.imbio.2022.152279_bib1629","doi-asserted-by":"crossref","first-page":"711997","DOI":"10.3389\/fimmu.2021.711997","article-title":"Advances in Development and Application of Influenza Vaccines","volume":"12","author":"Chen","year":"2021","journal-title":"Frontiers in immunology"},{"key":"10.1016\/j.imbio.2022.152279_b0170","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/jm2013503","article-title":"Design, Synthesis, and in Vitro Biological Evaluation of 1H\u20131,2,3-Triazole-4-carboxamide Derivatives as New Anti-influenza A Agents Targeting Virus Nucleoprotein","volume":"55","author":"Cheng","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.imbio.2022.152279_b0175","series-title":"B Cell Responses to Influenza Infection and Vaccination","first-page":"381","author":"Chiu","year":"2015"},{"key":"10.1016\/j.imbio.2022.152279_bib1724","series-title":"Influenza Vaccine Effectiveness Network, the Influenza Hospitalization Surveillance Network, and the Assessment Branch, Immunization Services Division","first-page":"e368","volume":"71","author":"Chung","year":"2020"},{"key":"10.1016\/j.imbio.2022.152279_b0185","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1126\/science.357.6357.1222","article-title":"Why is the flu vaccine so mediocre?","volume":"357","author":"Cohen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.imbio.2022.152279_b0190","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nature06956","article-title":"Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants","volume":"453","author":"Collins","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2022.152279_b0195","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/jvi.10.4.795-800.1972","article-title":"Structure of the ribonucleoprotein of influenza virus","volume":"10","author":"Compans","year":"1972","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.imbio.2022.152279_bib1630","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0264-410X(97)00087-X","article-title":"Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients","volume":"15","author":"Conne","year":"1997","journal-title":"Vaccine"},{"issue":"6044","key":"10.1016\/j.imbio.2022.152279_bib1631","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.imbio.2022.152279_b0200","first-page":"25","article-title":"An overview of serum antibody responses to influenza virus antigens","volume":"115","author":"Couch","year":"2003","journal-title":"Dev Biol (Basel)"},{"issue":"6","key":"10.1016\/j.imbio.2022.152279_bib1632","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.imbio.2022.152279_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-1702(03)00159-X","article-title":"Trafficking of viral genomic RNA into and out of the nucleus: Influenza, Thogoto and Borna disease viruses","volume":"95","author":"Cros","year":"2003","journal-title":"Virus Res."},{"issue":"22","key":"10.1016\/j.imbio.2022.152279_bib1633","doi-asserted-by":"crossref","first-page":"15808","DOI":"10.1016\/S0021-9258(17)40752-6","article-title":"Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly","volume":"269","author":"Crouch","year":"1994","journal-title":"The Journal of biological chemistry"},{"issue":"15","key":"10.1016\/j.imbio.2022.152279_bib1634","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1021\/bi8022703","article-title":"Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343","volume":"48","author":"Crouch","year":"2009","journal-title":"Biochemistry"},{"issue":"47","key":"10.1016\/j.imbio.2022.152279_bib1635","doi-asserted-by":"crossref","first-page":"40681","DOI":"10.1074\/jbc.M111.300673","article-title":"Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo","volume":"286","author":"Crouch","year":"2011","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.imbio.2022.152279_b0220","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm0905-909","article-title":"Threat of pandemic brings flu drug back to life","volume":"11","author":"Cyranoski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2022.152279_b0225","doi-asserted-by":"crossref","first-page":"e1000473","DOI":"10.1371\/journal.ppat.1000473","article-title":"Influenza B Virus Ribonucleoprotein Is a Potent Activator of the Antiviral Kinase PKR","volume":"5","author":"Dauber","year":"2009","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1637","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: optimization of M2-based constructs","volume":"337","author":"De Filette","year":"2005","journal-title":"Virology"},{"issue":"44\u201346","key":"10.1016\/j.imbio.2022.152279_bib1636","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.vaccine.2006.05.082","article-title":"Improved design and intranasal delivery of an M2e-based human influenza A vaccine","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_bib1638","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2005.08.061","article-title":"The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b0230","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C","article-title":"Mismatch between the 1997\/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly","volume":"61","author":"de Jong","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0235","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1128\/jvi.69.4.2427-2433.1995","article-title":"Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs","volume":"69","author":"De la Luna","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0240","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(80)90486-9","article-title":"Nonviral oligonucleotides at the 5\u2032 terminus of cytoplasmic influenza viral mRNA deduced from cloned complete genomic sequences","volume":"21","author":"Dhar","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0245","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.imbio.2022.152279_b0250","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1128\/JVI.02548-12","article-title":"TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation","volume":"87","author":"Di Pietro","year":"2013","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1639","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201700645","article-title":"Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine","volume":"13","author":"Dong","year":"2018","journal-title":"Biotechnology journal"},{"issue":"6100","key":"10.1016\/j.imbio.2022.152279_bib1641","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science (New York, N.Y.)"},{"issue":"12","key":"10.1016\/j.imbio.2022.152279_bib1640","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1128\/JVI.02975-12","article-title":"Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin","volume":"87","author":"Dreyfus","year":"2013","journal-title":"Journal of virology"},{"key":"10.1016\/j.imbio.2022.152279_b0260","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1128\/JVI.00069-10","article-title":"Differential Activation of NK Cells by Influenza A Pseudotype H5N1 and 1918 and 2009 Pandemic H1N1 Viruses","volume":"84","author":"Du","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0265","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1099\/0022-1317-83-2-403","article-title":"Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5\u2032 sequence: Evidence from a plasmid-driven system","volume":"83","author":"Duhaut","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"68","key":"10.1016\/j.imbio.2022.152279_b0270","first-page":"7","article-title":"Tissue-resident monocytes promote the establishment of lung-resident CD8 T cell memory following influenza infection","volume":"196","author":"Dunbar","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0275","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/fampra\/cms059","article-title":"Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials","volume":"30","author":"Ebell","year":"2012","journal-title":"Fam. Pract."},{"key":"10.1016\/j.imbio.2022.152279_bib1642","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/infdis\/jiz017","article-title":"Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection","volume":"219","author":"Eichelberger","year":"2019","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.imbio.2022.152279_b0280","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody Recognition of a Highly Conserved Influenza Virus Epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.imbio.2022.152279_b0285","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"issue":"7417","key":"10.1016\/j.imbio.2022.152279_bib1644","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2022.152279_bib1645","doi-asserted-by":"crossref","unstructured":"El Bakkouri, K., Descamps, F., De Filette, M., Smet, A., Festjens, E., Birkett, A., Van Rooijen, N., Verbeek, S., Fiers, W., & Saelens, X. (2011). Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. Journal of immunology (Baltimore, Md. : 1950), 186(2), 1022\u20131031. https:\/\/doi.org\/10.4049\/jimmunol.0902147.","DOI":"10.4049\/jimmunol.0902147"},{"key":"10.1016\/j.imbio.2022.152279_b0295","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1128\/JVI.74.12.5556-5561.2000","article-title":"Characterization of Influenza Virus NS1 Protein by Using a Novel Helper-Virus-Free Reverse Genetic System","volume":"74","author":"Enami","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0300","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0042-6822(91)90776-8","article-title":"An influenza virus containing nine different RNA segments","volume":"185","author":"Enami","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.imbio.2022.152279_b0290","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1128\/jvi.68.3.1432-1437.1994","article-title":"Influenza virus NS1 protein stimulates translation of the M1 protein","volume":"68","author":"Enami","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_bib1646","doi-asserted-by":"crossref","unstructured":"Estenssoro, E., R\u00edos, F. G., Apeztegu\u00eda, C., Reina, R., Neira, J., Ceraso, D. H., Orlandi, C., Valentini, R., Tiribelli, N., Brizuela, M., Balasini, C., Mare, S., Domeniconi, G., Ilutovich, S., G\u00f3mez, A., Giuliani, J., Barrios, C., Valdez, P., & Registry of the Argentinian Society of Intensive Care SATI (2010). Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. American journal of respiratory and critical care medicine, 182(1), 41\u201348. https:\/\/doi.org\/10.1164\/201001-0037OC.","DOI":"10.1164\/201001-0037OC"},{"key":"10.1016\/j.imbio.2022.152279_b0305","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tim.2010.06.010","article-title":"BST-2\/tetherin: a new component of the innate immune response to enveloped viruses","volume":"18","author":"Evans","year":"2010","journal-title":"Trends Microbiol."},{"issue":"23\u201324","key":"10.1016\/j.imbio.2022.152279_bib1780","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152279_b0310","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.vaccine.2019.04.074","article-title":"mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials","volume":"37","author":"Feldman","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152279_b0315","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/314859","article-title":"In Vivo and In Vitro Induction of MxA Protein in Peripheral Blood Mononuclear Cells from Patients Chronically Infected with Hepatitis C Virus","volume":"180","author":"Fern\u00e1ndez","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2022.152279_b0320","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1128\/JVI.02381-05","article-title":"Influenza Virus Evades Innate and Adaptive Immunity via the NS1 Protein","volume":"80","author":"Fernandez-Sesma","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0325","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.20080124","article-title":"An antiinflammatory role for IKK\u03b2 through the inhibition of \u201cclassical\u201d macrophage activation","volume":"205","author":"Fong","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2022.152279_b0330","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/j.1460-2075.1994.tb06310.x","article-title":"Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport","volume":"13","author":"Fortes","year":"1994","journal-title":"The EMBO Journal"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1647","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1073\/pnas.1319058110","article-title":"A common solution to group 2 influenza virus neutralization","volume":"111","author":"Friesen","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imbio.2022.152279_b0335","doi-asserted-by":"crossref","first-page":"e1004960","DOI":"10.1371\/journal.ppat.1004960","article-title":"TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase","volume":"11","author":"Fu","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2022.152279_bib1648","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1038\/ncomms12780","article-title":"A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve","volume":"7","author":"Fu","year":"2016","journal-title":"Nature communications"},{"key":"10.1016\/j.imbio.2022.152279_b0345","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1073\/pnas.0437772100","article-title":"Selective incorporation of influenza virus RNA segments into virions","volume":"100","author":"Fujii","year":"2003","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.imbio.2022.152279_b0340","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1128\/JVI.79.6.3766-3774.2005","article-title":"Importance of both the Coding and the Segment-Specific Noncoding Regions of the Influenza A Virus NS Segment for Its Efficient Incorporation into Virions","volume":"79","author":"Fujii","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0350","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00428-003-0898-8","article-title":"The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling","volume":"444","author":"Fujimura","year":"2004","journal-title":"Virchows Arch."},{"key":"10.1016\/j.imbio.2022.152279_b0355","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/j.1460-2075.1994.tb06264.x","article-title":"Fine structure of influenza A virus observed by electron cryo-microscopy","volume":"13","author":"Fujiyoshi","year":"1994","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.imbio.2022.152279_b0360","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.imbio.2022.152279_b0365","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05732","article-title":"TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity","volume":"446","author":"Gack","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2022.152279_b0370","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2009.04.006","article-title":"Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I","volume":"5","author":"Gack","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.imbio.2022.152279_b0375","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.chom.2009.09.005","article-title":"Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes","volume":"6","author":"Gannag\u00e9","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.imbio.2022.152279_b0380","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/cmi.12005","article-title":"Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK","volume":"14","author":"Gao","year":"2012","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.imbio.2022.152279_b0385","doi-asserted-by":"crossref","first-page":"e64443","DOI":"10.1371\/journal.pone.0064443","article-title":"Complement C5 Activation during Influenza A Infection in Mice Contributes to Neutrophil Recruitment and Lung Injury","volume":"8","author":"Garcia","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imbio.2022.152279_b0390","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1128\/CDLI.5.5.604-608.1998","article-title":"Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection","volume":"5","author":"Gentile","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0395","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1084\/jem.20071365","article-title":"Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells","volume":"205","author":"GeurtsvanKessel","year":"2008","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1649","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molimm.2013.11.010","article-title":"Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation","volume":"58","author":"Ghannam","year":"2014","journal-title":"Molecular immunology"},{"issue":"8916","key":"10.1016\/j.imbio.2022.152279_bib1650","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(94)92758-8","article-title":"Immunogenicity of new virosome influenza vaccine in elderly people","volume":"344","author":"Gl\u00fcck","year":"1994","journal-title":"Lancet (London, England)"},{"issue":"47","key":"10.1016\/j.imbio.2022.152279_bib1651","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1021\/bi4010683","article-title":"Molecular mechanisms of inhibition of influenza by surfactant protein D revealed by large-scale molecular dynamics simulation","volume":"52","author":"Goh","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.imbio.2022.152279_bib1652","doi-asserted-by":"crossref","unstructured":"Gonzalez, S. F., Jayasekera, J. P., & Carroll, M. C. (2008). Complement and natural antibody are required in the long-term memory response to influenza virus. Vaccine, 26 Suppl 8, I86\u2013I93. https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.057.","DOI":"10.1016\/j.vaccine.2008.11.057"},{"key":"10.1016\/j.imbio.2022.152279_b0400","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature13590","article-title":"Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5\u2032-diphosphates","volume":"514","author":"Goubau","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2022.152279_b0405","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coviro.2016.01.016","article-title":"Human influenza viruses and CD8 + T cell responses","volume":"16","author":"Grant","year":"2016","journal-title":"Current Opinion in Virology"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b0410","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/jvi.40.1.323-328.1981","article-title":"Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion","volume":"40","author":"Gregoriades","year":"1981","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0415","doi-asserted-by":"crossref","first-page":"13468","DOI":"10.1073\/pnas.1107032108","article-title":"Structural basis for the sequence-specific recognition of human ISG15 by the NS1 protein of influenza B virus","volume":"108","author":"Guan","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.imbio.2022.152279_b0420","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1189\/jlb.0610319","article-title":"Evasion of natural killer cells by influenza virus","volume":"89","author":"Guo","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.imbio.2022.152279_b0425","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_bib1773","doi-asserted-by":"crossref","unstructured":"H\u00e5kansson, K., Lim, N. K., Hoppe, H. J., & Reid, K. B. (1999). Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure (London, England : 1993), 7(3), 255\u2013264. https:\/\/doi.org\/10.1016\/s0969-2126(99)80036-7.","DOI":"10.1016\/S0969-2126(99)80036-7"},{"key":"10.1016\/j.imbio.2022.152279_b0430","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/fmb.09.108","article-title":"Innate immune evasion strategies of influenza viruses","volume":"5","author":"Hale","year":"2010","journal-title":"Future Microbiology"},{"key":"10.1016\/j.imbio.2022.152279_b0435","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/ane.12629","article-title":"The mechanisms of sudden-onset type adverse reactions to oseltamivir","volume":"135","author":"Hama","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.imbio.2022.152279_b0440","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.vaccine.2017.01.018","article-title":"Improving the selection and development of influenza vaccine viruses \u2013 Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18\u201320 November 2015","volume":"35","author":"Hampson","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152279_b0445","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.2010.05829.x","article-title":"Structural basis of influenza virus neutralization","volume":"1217","author":"Han","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4\u20135","key":"10.1016\/j.imbio.2022.152279_bib1653","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1078\/0171-2985-00150","article-title":"Lung surfactant protein D (SP-D) and the molecular diverted descendants: conglutinin, CL-43 and CL-46","volume":"205","author":"Hansen","year":"2002","journal-title":"Immunobiology"},{"issue":"7","key":"10.1016\/j.imbio.2022.152279_b0450","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1128\/jvi.66.7.4358-4363.1992","article-title":"Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin","volume":"66","author":"Hartley","year":"1992","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1654","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s007050050060","article-title":"Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice","volume":"142","author":"Hartley","year":"1997","journal-title":"Archives of virology"},{"key":"10.1016\/j.imbio.2022.152279_b0455","series-title":"The Role of Viral Envelope Protein Glycosylation in Pathogenesis of Influenza A Virus","first-page":"12","author":"Hartshorn","year":"2016"},{"key":"10.1016\/j.imbio.2022.152279_b0460","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1172\/JCI116345","article-title":"Human mannose-binding protein functions as an opsonin for influenza A viruses","volume":"91","author":"Hartshorn","year":"1993","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.imbio.2022.152279_b0465","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI117323","article-title":"Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses","volume":"94","author":"Hartshorn","year":"1994","journal-title":"J. Clin. Investig."},{"issue":"5 Pt 1","key":"10.1016\/j.imbio.2022.152279_bib1655","first-page":"L753","article-title":"Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A","volume":"271","author":"Hartshorn","year":"1996","journal-title":"The American journal of physiology"},{"key":"10.1016\/j.imbio.2022.152279_b0470","doi-asserted-by":"crossref","first-page":"L1066","DOI":"10.1152\/ajplung.00057.2003","article-title":"Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses","volume":"285","author":"Hartshorn","year":"2003","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.imbio.2022.152279_b0475","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/BJ20050695","article-title":"Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation","volume":"393","author":"Hartshorn","year":"2005","journal-title":"Biochem. J"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1656","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1465-9921-9-65","article-title":"Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D","volume":"9","author":"Hartshorn","year":"2008","journal-title":"Respiratory research"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1657","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-3083.2010.02409.x","article-title":"Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: dissociation of mannan-binding and antiviral activity","volume":"72","author":"Hartshorn","year":"2010","journal-title":"Scandinavian journal of immunology"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1658","doi-asserted-by":"crossref","first-page":"L79","DOI":"10.1152\/ajplung.00223.2009","article-title":"Viral aggregating and opsonizing activity in collectin trimers","volume":"298","author":"Hartshorn","year":"2010","journal-title":"American journal of physiology. Lung cellular and molecular physiology"},{"key":"10.1016\/j.imbio.2022.152279_b0480","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nri2251","article-title":"Shaping and reshaping CD8+ T-cell memory","volume":"8","author":"Harty","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0485","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1128\/JVI.78.16.8565-8572.2004","article-title":"Pulmonary Collectins Modulate Strain-Specific Influenza A Virus Infection and Host Responses","volume":"78","author":"Hawgood","year":"2004","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1659","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2005.02.006","article-title":"C5a negatively regulates toll-like receptor 4-induced immune responses","volume":"22","author":"Hawlisch","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2022.152279_b0490","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/591851","article-title":"Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?","volume":"48","author":"Hayden","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imbio.2022.152279_b0495","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QCO.0000000000000532","article-title":"Influenza virus polymerase inhibitors in clinical development","volume":"32","author":"Hayden","year":"2019","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1016\/j.imbio.2022.152279_b0500","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.imbio.2022.152279_bib1660","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines","volume":"80","author":"He","year":"2006","journal-title":"Journal of virology"},{"key":"10.1016\/j.imbio.2022.152279_b0505","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.4049\/jimmunol.181.10.6984","article-title":"CD4+ and CD8+ T cells exhibit differential requirements for CCR7-mediated antigen transport during influenza infection","volume":"181","author":"Heer","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imbio.2022.152279_b0510","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(92)90219-3","article-title":"Unpacking the incoming influenza virus","volume":"69","author":"Helenius","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0515","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2015.08.033","article-title":"Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity","volume":"486","author":"Herv\u00e9","year":"2015","journal-title":"Virology"},{"issue":"33","key":"10.1016\/j.imbio.2022.152279_bib1661","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1016\/j.vaccine.2009.05.029","article-title":"Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine","volume":"27","author":"Herzog","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1662","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.virusres.2012.08.003","article-title":"The number and position of N-linked glycosylation sites in the hemagglutinin determine differential recognition of seasonal and 2009 pandemic H1N1 influenza virus by porcine surfactant protein D","volume":"169","author":"Hillaire","year":"2012","journal-title":"Virus research"},{"key":"10.1016\/j.imbio.2022.152279_bib1663","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virusres.2014.08.019","article-title":"Assessment of the antiviral properties of recombinant surfactant protein D against influenza B virus in vitro","volume":"195","author":"Hillaire","year":"2015","journal-title":"Virus research"},{"issue":"10","key":"10.1016\/j.imbio.2022.152279_b0520","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.4049\/jimmunol.177.10.7346","article-title":"Induction of Tolerance to Innocuous Inhaled Antigen Relies on a CCR7-Dependent Dendritic Cell-Mediated Antigen Transport to the Bronchial Lymph Node","volume":"177","author":"Hintzen","year":"2006","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2022.152279_b0525","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.4049\/jimmunol.1100987","article-title":"Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells","volume":"187","author":"Ho","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.imbio.2022.152279_b0530","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0042-6822(91)90115-R","article-title":"Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds","volume":"183","author":"Holsinger","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.imbio.2022.152279_bib1664","doi-asserted-by":"crossref","unstructured":"Hong, M., Lee, P. S., Hoffman, R. M., Zhu, X., Krause, J. C., Laursen, N. S., Yoon, S. I., Song, L., Tussey, L., Crowe, J. E., Jr, Ward, A. B., & Wilson, I. A. (2013). Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. Journal of virology, 87(22), 12471\u201312480. https:\/\/doi.org\/10.1128\/JVI.01388-13.","DOI":"10.1128\/JVI.01388-13"},{"key":"10.1016\/j.imbio.2022.152279_b0535","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrmicro1208","article-title":"Influenza: lessons from past pandemics, warnings from current incidents","volume":"3","author":"Horimoto","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.imbio.2022.152279_b0540","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fimmu.2018.01368","article-title":"The Role and Molecular Mechanism of Action of Surfactant Protein D in Innate Host Defense Against Influenza A Virus","volume":"9","author":"Hsieh","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2022.152279_bib1665","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/21645515.2020.1721994","article-title":"Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6-35 months in China","volume":"16","author":"Hu","year":"2020","journal-title":"Human vaccines & immunotherapeutics"},{"key":"10.1016\/j.imbio.2022.152279_b0545","doi-asserted-by":"crossref","first-page":"e27512","DOI":"10.1371\/journal.pone.0027512","article-title":"Comparative Analyses of Pandemic H1N1 and Seasonal H1N1, H3N2, and Influenza B Infections Depict Distinct Clinical Pictures in Ferrets","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.imbio.2022.152279_bib1666","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1371\/journal.pmed.0030441","article-title":"Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection","volume":"3","author":"Huber","year":"2006","journal-title":"PLoS medicine"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1667","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152279_b0550","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2165\/11531450-000000000-00000","article-title":"Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses","volume":"69","author":"Hurt","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.imbio.2022.152279_b0555","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","article-title":"Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa","volume":"83","author":"Hurt","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.imbio.2022.152279_b0560","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01200-09","article-title":"Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation","volume":"83","author":"Hurt","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0565","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ni.1861","article-title":"Influenza virus activates inflammasomes via its intracellular M2 ion channel","volume":"11","author":"Ichinohe","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0575","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccm.2016.11.008","article-title":"Antiviral Treatments","volume":"38","author":"Ison","year":"2017","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.imbio.2022.152279_b0580","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/viro.1996.8323","article-title":"Receptor Specificity of Influenza A Viruses Correlates with the Agglutination of Erythrocytes from Different Animal Species","volume":"227","author":"Ito","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.imbio.2022.152279_b0585","first-page":"A146","article-title":"Surfactant protein A (SP-A) prevents infection of cells by influenza A virus","volume":"148","author":"Iwaarden","year":"1993","journal-title":"Am Rev Resp Dis"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_b0590","first-page":"e01463","article-title":"Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model."},{"key":"10.1016\/j.imbio.2022.152279_bib1668","doi-asserted-by":"crossref","unstructured":"Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., Jasuja, S., Deutscher, M., Chen, S., Walker, J. D., Duchin, J. S., Lett, S., Soliva, S., Wells, E. V., Swerdlow, D., Uyeki, T. M., \u2026 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team (2009). Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. The New England journal of medicine, 361(20), 1935\u20131944. https:\/\/doi.org\/10.1056\/NEJMoa0906695.","DOI":"10.1056\/NEJMoa0906695"},{"key":"10.1016\/j.imbio.2022.152279_b0595","unstructured":"Janssen, R., Development, L.L.C. 2020. A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection."},{"issue":"7","key":"10.1016\/j.imbio.2022.152279_bib1669","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JVI.02128-06","article-title":"Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity","volume":"81","author":"Jayasekera","year":"2007","journal-title":"Journal of virology"},{"issue":"apr09 2","key":"10.1016\/j.imbio.2022.152279_b0600","first-page":"g2545","article-title":"Oseltamivir for influenza in adults and children: Systematic review of clinical study reports and summary of regulatory comments","volume":"348","author":"Jefferson","year":"2014","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.imbio.2022.152279_b0605","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane database of systematic reviews","author":"Jefferson","year":"2014","journal-title":"CD008965."},{"key":"10.1016\/j.imbio.2022.152279_b0610","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/infdis\/jiu334","article-title":"Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity in Intravenous Immunoglobulin as a Potential Therapeutic Against Emerging Influenza Viruses","volume":"210","author":"Jegaskanda","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2022.152279_bib1670","doi-asserted-by":"crossref","unstructured":"Jegerlehner, A., Schmitz, N., Storni, T., & Bachmann, M. F. (2004). Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. Journal of immunology (Baltimore, Md. : 1950), 172(9), 5598\u20135605. https:\/\/doi.org\/10.4049\/jimmunol.172.9.5598.","DOI":"10.4049\/jimmunol.172.9.5598"},{"key":"10.1016\/j.imbio.2022.152279_b0615","doi-asserted-by":"crossref","first-page":"209","DOI":"10.9758\/cpn.2015.13.2.209","article-title":"Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report","volume":"13","author":"Jeon","year":"2015","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"Pt 9","key":"10.1016\/j.imbio.2022.152279_bib1671","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1099\/vir.0.81199-0","article-title":"Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization","volume":"86","author":"Ji","year":"2005","journal-title":"The Journal of general virology"},{"key":"10.1016\/j.imbio.2022.152279_b0620","doi-asserted-by":"crossref","first-page":"e13927","DOI":"10.1371\/journal.pone.0013927","article-title":"Influenza Virus Non-Structural Protein 1 (NS1) Disrupts Interferon Signaling","volume":"5","author":"Jia","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imbio.2022.152279_bib1673","doi-asserted-by":"crossref","unstructured":"Job, E. R., Deng, Y. M., Tate, M. D., Bottazzi, B., Crouch, E. C., Dean, M. M., Mantovani, A., Brooks, A. G., & Reading, P. C. (2010). Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. Journal of immunology (Baltimore, Md. : 1950), 185(7), 4284\u20134291. https:\/\/doi.org\/10.4049\/jimmunol.1001613.","DOI":"10.4049\/jimmunol.1001613"},{"key":"10.1016\/j.imbio.2022.152279_b0625","doi-asserted-by":"crossref","first-page":"e59623","DOI":"10.1371\/journal.pone.0059623","article-title":"Serum Amyloid P Is a Sialylated Glycoprotein Inhibitor of Influenza A Viruses","volume":"8","author":"Job","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_bib1672","first-page":"2169","article-title":"Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses","volume":"190","author":"Job","year":"2013","journal-title":"Journal of immunology (Baltimore, Md.\u202f: 1950)"},{"key":"10.1016\/j.imbio.2022.152279_bib1781","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-018-0093-1","article-title":"Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs","volume":"3","author":"Job","year":"2018","journal-title":"NPJ vaccines"},{"issue":"12","key":"10.1016\/j.imbio.2022.152279_bib1674","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1586\/erv.11.130","article-title":"Influenza viral neuraminidase: the forgotten antigen","volume":"10","author":"Johansson","year":"2011","journal-title":"Expert review of vaccines"},{"key":"10.1016\/j.imbio.2022.152279_b0630","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/irv.12412","article-title":"The ecology and adaptive evolution of influenza A interspecies transmission","volume":"11","author":"Joseph","year":"2017","journal-title":"Influenza Other Respir. Viruses"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1675","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0635","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1359-6101(00)00026-5","article-title":"Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression","volume":"12","author":"Julkunen","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1676","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0640","first-page":"187","article-title":"Influenza treatment and prophylaxis with neuraminidase inhibitors: a review","volume":"6","author":"Kamali","year":"2013","journal-title":"Infection and drug resistance"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1677","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","volume":"20","author":"Kanekiyo","year":"2019","journal-title":"Nature immunology"},{"key":"10.1016\/j.imbio.2022.152279_b0645","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nbt.1638","article-title":"Identification of influenza A nucleoprotein as an antiviral target","volume":"28","author":"Kao","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"16","key":"10.1016\/j.imbio.2022.152279_bib1678","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.0801367105","article-title":"Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies","volume":"105","author":"Kashyap","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imbio.2022.152279_b0650","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0655","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1432-1033.1985.tb09312.x","article-title":"Differential regulation of interferon-induced mRNAs and c-myc mRNA by alpha- and gamma-interferons","volume":"153","author":"Kelly","year":"1985","journal-title":"Eur. J. Biochem."},{"issue":"7","key":"10.1016\/j.imbio.2022.152279_bib1681","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/v8070183","article-title":"Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines","volume":"8","author":"Kim","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.imbio.2022.152279_bib1679","doi-asserted-by":"crossref","unstructured":"Kim, A. H., Dimitriou, I. D., Holland, M. C., Mastellos, D., Mueller, Y. M., Altman, J. D., Lambris, J. D., & Katsikis, P. D. (2004). Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. Journal of immunology (Baltimore, Md. : 1950), 173(4), 2524\u20132529. https:\/\/doi.org\/10.4049\/jimmunol.173.4.2524.","DOI":"10.4049\/jimmunol.173.4.2524"},{"issue":"20","key":"10.1016\/j.imbio.2022.152279_bib1682","doi-asserted-by":"crossref","first-page":"e00969","DOI":"10.1128\/JVI.00969-18","article-title":"Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination","volume":"92","author":"Kim","year":"2018","journal-title":"Journal of virology"},{"issue":"8","key":"10.1016\/j.imbio.2022.152279_bib1680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010755","article-title":"Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle","volume":"18","author":"Kim","year":"2022","journal-title":"PLoS pathogens"},{"issue":"34","key":"10.1016\/j.imbio.2022.152279_bib1683","doi-asserted-by":"crossref","first-page":"24496","DOI":"10.1074\/jbc.M600651200","article-title":"Correction of pulmonary abnormalities in Sftpd-\/- mice requires the collagenous domain of surfactant protein D","volume":"281","author":"Kingma","year":"2006","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.imbio.2022.152279_b0660","doi-asserted-by":"crossref","first-page":"20390","DOI":"10.2807\/ese.18.05.20390-en","article-title":"Low and decreasing vaccine effectiveness against influenza A(H3) in 2011\/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case\u2013control study","volume":"18","author":"Kissling","year":"2013","journal-title":"Eurosurveillance"},{"issue":"45","key":"10.1016\/j.imbio.2022.152279_b0665","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1016\/j.vaccine.2012.07.089","article-title":"WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011","volume":"30","author":"Klimov","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152279_b0670","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1128\/AAC.00474-10","article-title":"Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus Infection","volume":"54","author":"Kohno","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1684","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14760584.2017.1240041","article-title":"M2-based influenza vaccines: recent advances and clinical potential","volume":"16","author":"Kolpe","year":"2017","journal-title":"Expert review of vaccines"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150700","article-title":"Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes","volume":"11","author":"Kon","year":"2016","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1686","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.virol.2012.06.001","article-title":"Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs","volume":"432","author":"Kong","year":"2012","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1687","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm0402-373","article-title":"Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection","volume":"8","author":"Kopf","year":"2002","journal-title":"Nature medicine"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1688","doi-asserted-by":"crossref","first-page":"00060","DOI":"10.1183\/23120541.00060-2017","article-title":"Immunogenicity and safety of subunit influenza vaccines in pregnant women","volume":"4","author":"Kostinov","year":"2018","journal-title":"ERJ open research"},{"issue":"12","key":"10.1016\/j.imbio.2022.152279_bib1689","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1080\/21645515.2018.1507585","article-title":"Prospective randomized open-label comparative study of immunogenicity after subunit and polymeric subunit influenza vaccines administration among mothers and infants","volume":"14","author":"Kostinov","year":"2018","journal-title":"Human vaccines & immunotherapeutics"},{"key":"10.1016\/j.imbio.2022.152279_bib1690","doi-asserted-by":"crossref","unstructured":"Koutsakos, M., Nguyen, T., & Kedzierska, K. (2019). With a Little Help from T Follicular Helper Friends: Humoral Immunity to Influenza Vaccination. Journal of immunology (Baltimore, Md. : 1950), 202(2), 360\u2013367. https:\/\/doi.org\/10.4049\/jimmunol.1800986.","DOI":"10.4049\/jimmunol.1800986"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1691","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nature reviews. Drug discovery"},{"key":"10.1016\/j.imbio.2022.152279_b0675","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","article-title":"Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain","volume":"219","author":"Krammer","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"20","key":"10.1016\/j.imbio.2022.152279_bib1692","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1128\/JVI.00700-11","article-title":"A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin","volume":"85","author":"Krause","year":"2011","journal-title":"Journal of virology"},{"key":"10.1016\/j.imbio.2022.152279_b0680","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2011.09.022","article-title":"Immune responses to influenza virus infection","volume":"162","author":"Kreijtz","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.imbio.2022.152279_b0685","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0092-8674(79)90052-7","article-title":"Are the 5\u2032 ends of influenza viral mrnas synthesized in vivo donated by host mRNAs?","volume":"18","author":"Krug","year":"1979","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0690","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1099\/vir.2008.007260-0","article-title":"High prevalence of amantadine resistance among circulating European porcine influenza A viruses","volume":"90","author":"Krumbholz","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0695","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00430-010-0176-8","article-title":"Current knowledge on PB1-F2 of influenza A viruses","volume":"200","author":"Krumbholz","year":"2011","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_bib1693","doi-asserted-by":"crossref","unstructured":"Kuiken, T., & Taubenberger, J. K. (2008). Pathology of human influenza revisited. Vaccine, 26 Suppl 4(Suppl 4), D59\u2013D66. https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.025.","DOI":"10.1016\/j.vaccine.2008.07.025"},{"key":"10.1016\/j.imbio.2022.152279_b0700","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08830185.2010.529976","article-title":"Pathogen Recognition by the Innate Immune System","volume":"30","author":"Kumar","year":"2011","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1694","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jpids\/pit053","article-title":"Overview of Influenza Vaccines in Children","volume":"2","author":"Lafond","year":"2013","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"key":"10.1016\/j.imbio.2022.152279_b0705","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.bi.52.070183.002343","article-title":"The Gene Structure and Replication of Influenza Virus","volume":"52","author":"Lamb","year":"1983","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.imbio.2022.152279_b0715","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0168-9525(91)90326-L","article-title":"Diversity of coding strategies in influenza viruses","volume":"7","author":"Lamb","year":"1991","journal-title":"Trends Genet."},{"key":"10.1016\/j.imbio.2022.152279_b0710","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4049\/jimmunol.128.1.233","article-title":"Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones","volume":"128","author":"Lamb","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0720","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0725","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1128\/JVI.00150-11","article-title":"Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance","volume":"85","author":"LaMere","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_bib1696","first-page":"323","article-title":"Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies","volume":"386","author":"Lee","year":"2015","journal-title":"Current topics in microbiology and immunology"},{"key":"10.1016\/j.imbio.2022.152279_bib1695","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1038\/ncomms4614","article-title":"Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus","volume":"5","author":"Lee","year":"2014","journal-title":"Nature communications"},{"key":"10.1016\/j.imbio.2022.152279_b0730","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.02335-12","article-title":"Structure-Based Discovery of the Novel Antiviral Properties of Naproxen against the Nucleoprotein of Influenza A Virus","volume":"57","author":"Lejal","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.imbio.2022.152279_b0735","doi-asserted-by":"crossref","first-page":"10704","DOI":"10.1128\/JVI.01166-12","article-title":"Entry of Influenza A Virus with a 2,6-Linked Sialic Acid Binding Preference Requires Host Fibronectin","volume":"86","author":"Leung","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0740","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.4049\/jimmunol.167.10.5868","article-title":"Surfactant Protein D Enhances Clearance of Influenza A Virus from the Lung In Vivo","volume":"167","author":"LeVine","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0745","doi-asserted-by":"crossref","first-page":"L563","DOI":"10.1152\/ajplung.00280.2001","article-title":"Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection","volume":"282","author":"LeVine","year":"2002","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.imbio.2022.152279_b0755","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/emboj\/20.8.2078","article-title":"The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits","volume":"20","author":"Li","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.imbio.2022.152279_b0760","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1165\/ajrcmb.26.3.4584","article-title":"Surfactant Protein-A\u2013Deficient Mice Display an Exaggerated Early Inflammatory Response to a \u03b2 -Resistant Strain of Influenza A Virus","volume":"26","author":"Li","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b0750","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2006.01.005","article-title":"Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA","volume":"349","author":"Li","year":"2006","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1698","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4161\/hv.27329","article-title":"A randomized, controlled, blinded study of the safety, immunogenicity and batch consistency of Aleph inactivated split influenza vaccine made in China in Chinese people","volume":"10","author":"Li","year":"2014","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"8","key":"10.1016\/j.imbio.2022.152279_bib1697","first-page":"670","article-title":"Continuous Reassortment of Clade 2.3.4.4 H5N6 Highly Pathogenetic Avian Influenza Viruses Demonstrating High Risk to","volume":"9","author":"Li","year":"2020","journal-title":"Public Health. Pathogens (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1699","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cid\/cis327","article-title":"Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans","volume":"55","author":"Lillie","year":"2012","journal-title":"Clinical infectious diseases\u202f: an official publication of the Infectious Diseases Society of America"},{"issue":"8","key":"10.1016\/j.imbio.2022.152279_bib1700","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S2213-2600(19)30086-4","article-title":"Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study","volume":"7","author":"Lindsey","year":"2019","journal-title":"The Lancet. Respiratory medicine"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1701","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1038\/s41598-017-14891-y","article-title":"Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine","volume":"7","author":"Lingel","year":"2017","journal-title":"Scientific reports"},{"key":"10.1016\/j.imbio.2022.152279_b0765","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid rafts as a membrane-organizing principle","volume":"327","author":"Lingwood","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.imbio.2022.152279_b0775","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1099\/vir.0.19596-0","article-title":"Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity","volume":"85","author":"Liu","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0770","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","article-title":"Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol","volume":"38","author":"Liu","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2022.152279_b0780","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.1114981109","article-title":"Systematic identification of type I and type II interferon-induced antiviral factors","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.imbio.2022.152279_b0785","doi-asserted-by":"crossref","first-page":"14048","DOI":"10.1073\/pnas.1509745112","article-title":"Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein","volume":"112","author":"Liu","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9859","key":"10.1016\/j.imbio.2022.152279_b0790","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"The Lancet"},{"key":"10.1016\/j.imbio.2022.152279_b0795","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1101\/gad.8.15.1817","article-title":"The influenza virus NS1 protein: A novel inhibitor of pre-mRNA splicing","volume":"8","author":"Lu","year":"1994","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b0800","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/viro.1995.9937","article-title":"Binding of the Influenza Virus NS1 Protein to Double-Stranded RNA Inhibits the Activation of the Protein Kinase That Phosphorylates the eIF-2 Translation Initiation Factor","volume":"214","author":"Lu","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.imbio.2022.152279_b0805","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ni.2563","article-title":"Receptor interacting protein kinase 2\u2013mediated mitophagy regulates inflammasome activation during virus infection","volume":"14","author":"Lupfer","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0810","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1034\/j.1600-065X.2003.00058.x","article-title":"Extrafollicular antibody responses","volume":"194","author":"MacLennan","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2022.152279_b0815","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80413-6","article-title":"IL-12-Deficient Mice Are Defective in IFN\u03b3 Production and Type 1 Cytokine Responses","volume":"4","author":"Magram","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2022.152279_b0820","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3343\/alm.2012.32.4.276","article-title":"Erythrocyte Binding Preference of Human Pandemic Influenza Virus A and Its Effect on Antibody Response Detection","volume":"32","author":"Makkoch","year":"2012","journal-title":"Annals of Laboratory Medicine"},{"key":"10.1016\/j.imbio.2022.152279_b0825","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00726-008-0201-z","article-title":"Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation","volume":"37","author":"Malaisree","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.imbio.2022.152279_b0830","doi-asserted-by":"crossref","first-page":"e1003279","DOI":"10.1371\/journal.ppat.1003279","article-title":"Pandemic Influenza A Viruses Escape from Restriction by Human MxA through Adaptive Mutations in the Nucleoprotein","volume":"9","author":"M\u00e4nz","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2022.152279_b0835","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3390\/ijms18122649","article-title":"Influenza A Virus M2 Protein: Roles from Ingress to Egress","volume":"18","author":"Manzoor","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imbio.2022.152279_b0840","doi-asserted-by":"crossref","first-page":"9215","DOI":"10.1128\/JVI.00805-09","article-title":"Influenza Virus Directly Infects Human Natural Killer Cells and Induces Cell Apoptosis","volume":"83","author":"Mao","year":"2009","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.imbio.2022.152279_bib1702","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026335","article-title":"A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus","volume":"6","author":"Marcelin","year":"2011","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b0845","first-page":"8","article-title":"Transport of incoming influenza virus nucleocapsids into the nucleus","volume":"2","author":"Martin","year":"1992","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b0850","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0092-8674(91)90576-K","article-title":"Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import","volume":"67","author":"Martin","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0855","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41577-019-0243-3","article-title":"Novel vaccine technologies for the 21st century","volume":"20","author":"Mascola","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2022.152279_b0860","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1128\/JVI.80.7.3515-3522.2006","article-title":"Tumor Necrosis Factor Alpha Enhances Influenza A Virus-Induced Expression of Antiviral Cytokines by Activating RIG-I Gene Expression","volume":"80","author":"Matikainen","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0865","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","article-title":"Neuraminidase Is Important for the Initiation of Influenza Virus Infection in Human Airway Epithelium","volume":"78","author":"Matrosovich","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0870","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.chom.2007.09.001","article-title":"Expression of the 1918 Influenza A Virus PB1-F2 Enhances the Pathogenesis of Viral and Secondary Bacterial Pneumonia","volume":"2","author":"McAuley","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.imbio.2022.152279_b0875","doi-asserted-by":"crossref","first-page":"e1003392","DOI":"10.1371\/journal.ppat.1003392","article-title":"Activation of the NLRP3 Inflammasome by IAV Virulence Protein PB1-F2 Contributes to Severe Pathophysiology and Disease","volume":"9","author":"McAuley","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2022.152279_b0880","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","article-title":"Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance","volume":"7","author":"McKimm-Breschkin","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.imbio.2022.152279_b0885","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"187","key":"10.1016\/j.imbio.2022.152279_bib1703","doi-asserted-by":"crossref","first-page":"187ra70","DOI":"10.1126\/scitranslmed.3005996","article-title":"Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses","volume":"5","author":"Medina","year":"2013","journal-title":"Science translational medicine"},{"key":"10.1016\/j.imbio.2022.152279_b0890","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid1504.181280","article-title":"Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007\u201308 season","volume":"15","author":"Meijer","year":"2009","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_b0895","first-page":"e00417","article-title":"Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A\/H1N1 Virus Healthy Human Challenge Model","volume":"7","author":"Memoli","year":"2016","journal-title":"Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A\/H1N1 Virus Healthy Human Challenge Model."},{"key":"10.1016\/j.imbio.2022.152279_b0900","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1128\/JVI.01815-09","article-title":"NKp46 O-Glycan Sequences That Are Involved in the Interaction with Hemagglutinin Type 1 of Influenza Virus","volume":"84","author":"Mendelson","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0905","doi-asserted-by":"crossref","first-page":"e60348","DOI":"10.1371\/journal.pone.0060348","article-title":"The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews","volume":"8","author":"Michiels","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imbio.2022.152279_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104545","article-title":"Antivirals targeting the polymerase complex of influenza viruses","volume":"169","author":"Mifsud","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.imbio.2022.152279_b0915","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3390\/v13102090","article-title":"Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract","volume":"13","author":"Mifsud","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.imbio.2022.152279_b0920","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1084\/jem.20130091","article-title":"Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4","volume":"210","author":"Mikhak","year":"2013","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.imbio.2022.152279_bib1704","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/infdis\/jiz583","article-title":"Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children","volume":"221","author":"Mohn","year":"2020","journal-title":"The Journal of infectious diseases"},{"issue":"8","key":"10.1016\/j.imbio.2022.152279_bib1705","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection","volume":"212","author":"Monto","year":"2015","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.imbio.2022.152279_bib1706","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3389\/fimmu.2018.01861","article-title":"Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus","volume":"9","author":"Morabito","year":"2018","journal-title":"Frontiers in immunology"},{"issue":"13","key":"10.1016\/j.imbio.2022.152279_bib1707","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.imbio.2022.152279_b0925","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMp0900648","article-title":"Global Transmission of Oseltamivir-Resistant Influenza","volume":"360","author":"Moscona","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2022.152279_bib1708","doi-asserted-by":"crossref","unstructured":"Mozdzanowska, K., Feng, J., Eid, M., Kragol, G., Cudic, M., Otvos, L., Jr, & Gerhard, W. (2003). Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine, 21(19-20), 2616\u20132626. https:\/\/doi.org\/10.1016\/s0264-410x(03)00040-9.","DOI":"10.1016\/S0264-410X(03)00040-9"},{"key":"10.1016\/j.imbio.2022.152279_b0930","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.virol.2006.05.008","article-title":"Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components","volume":"352","author":"Mozdzanowska","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.imbio.2022.152279_b0935","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajpath.2011.03.003","article-title":"IL-17\u2013Induced Pulmonary Pathogenesis during Respiratory Viral Infection and Exacerbation of Allergic Disease","volume":"179","author":"Mukherjee","year":"2011","journal-title":"The American Journal of Pathology"},{"issue":"7","key":"10.1016\/j.imbio.2022.152279_bib1709","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/eji.201242922","article-title":"Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine","volume":"43","author":"Mullarkey","year":"2013","journal-title":"European journal of immunology"},{"key":"10.1016\/j.imbio.2022.152279_b0940","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.iy.04.040186.002443","article-title":"The membrane attack complex of complement","volume":"4","author":"Muller-Eberhard","year":"1986","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0945","series-title":"The Systemic and Mucosal Immune Response of Humans to Influenza A Virus","first-page":"107","author":"Murphy","year":"1989"},{"key":"10.1016\/j.imbio.2022.152279_b0950","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0042-6822(88)90574-0","article-title":"Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling","volume":"164","author":"Murti","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.imbio.2022.152279_b0955","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fimmu.2020.00355","article-title":"Complement-Independent Modulation of Influenza A Virus Infection by Factor H","volume":"11","author":"Murugaiah","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_bib1711","doi-asserted-by":"crossref","unstructured":"Nachbagauer, R., & Krammer, F. (2017). Universal influenza virus vaccines and therapeutic antibodies. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 23(4), 222\u2013228. https:\/\/doi.org\/10.1016\/j.cmi.2017.02.009.","DOI":"10.1016\/j.cmi.2017.02.009"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1712","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","article-title":"An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies","volume":"14","author":"Nakamura","year":"2013","journal-title":"Cell host & microbe"},{"issue":"10","key":"10.1016\/j.imbio.2022.152279_bib1713","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nature medicine"},{"key":"10.1016\/j.imbio.2022.152279_b0960","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrg2053","article-title":"The evolution of epidemic influenza","volume":"8","author":"Nelson","year":"2007","journal-title":"Nat. Rev. Genet."},{"issue":"7","key":"10.1016\/j.imbio.2022.152279_b0965","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1097-2765(00)80099-4","article-title":"Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3\u2032 end formation of cellular pre-mRNAs","volume":"1","author":"Nemeroff","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.imbio.2022.152279_b0970","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/smvy.1996.0032","article-title":"Cytokine release and innate immunity in respiratory viral infection","volume":"7","author":"Neuzil","year":"1996","journal-title":"Seminars in Virology"},{"issue":"11","key":"10.1016\/j.imbio.2022.152279_bib1715","doi-asserted-by":"crossref","first-page":"L1036","DOI":"10.1152\/ajplung.00035.2014","article-title":"Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses","volume":"306","author":"Nikolaidis","year":"2014","journal-title":"American journal of physiology. Lung cellular and molecular physiology"},{"key":"10.1016\/j.imbio.2022.152279_b0975","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/JVI.80.7.3675-3678.2006","article-title":"Comparison of the Mutation Rates of Human Influenza A and B Viruses","volume":"80","author":"Nobusawa","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b0980","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b0985","doi-asserted-by":"crossref","first-page":"e17377","DOI":"10.1371\/journal.pone.0017377","article-title":"A Protective Role for Complement C3 Protein during Pandemic 2009 H1N1 and H5N1 Influenza A Virus Infection","volume":"6","author":"O'Brien","year":"2011","journal-title":"PLoS ONE"},{"issue":"21","key":"10.1016\/j.imbio.2022.152279_bib1716","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1128\/JVI.05397-11","article-title":"Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5","volume":"85","author":"Ohshima","year":"2011","journal-title":"Journal of virology"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_bib1717","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/jvi.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"Journal of virology"},{"key":"10.1016\/j.imbio.2022.152279_b0990","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.288.5468.1051","article-title":"Influenza B virus in seals","volume":"288","author":"Osterhaus","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.imbio.2022.152279_b0995","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/biom12020226","article-title":"New Insights into the Role of the Complement System in Human Viral Diseases","volume":"12","author":"Ostrycharz","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.imbio.2022.152279_b1000","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/nm1141","article-title":"Influenza: old and new threats","volume":"10","author":"Palese","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2022.152279_b1005","series-title":"Fields virology","author":"Palese","year":"2007"},{"key":"10.1016\/j.imbio.2022.152279_b1010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4049\/jimmunol.159.2.591","article-title":"Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells","volume":"159","author":"Pape","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b1015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b1020","first-page":"e02284","article-title":"Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A\/H1N1pdm","volume":"9","author":"Park","year":"2018","journal-title":"Virus."},{"key":"10.1016\/j.imbio.2022.152279_b1025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2217\/fvl.14.70","article-title":"Novel drugs targeting Toll-like receptors for antiviral therapy","volume":"9","author":"Patel","year":"2014","journal-title":"Future Virology"},{"key":"10.1016\/j.imbio.2022.152279_b1030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jiy633","article-title":"Influenza Vaccines: Good, but We Can Do Better","volume":"219","author":"Paules","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.imbio.2022.152279_b1035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1743-422X-9-251","article-title":"Receptor specificity and erythrocyte binding preferences of avian influenza viruses isolated from India","volume":"9","author":"Pawar","year":"2012","journal-title":"Virology Journal"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1718","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/187152809788681038","article-title":"The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses","volume":"8","author":"Peng","year":"2009","journal-title":"Inflammation & allergy drug targets"},{"key":"10.1016\/j.imbio.2022.152279_b1040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/mpat.1995.0056","article-title":"Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia","volume":"19","author":"Peper","year":"1995","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.imbio.2022.152279_b1045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.imbio.2022.152279_b1050","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.0902548106","article-title":"Mechanism of drug inhibition and drug resistance of influenza A M2 channel","volume":"106","author":"Pielak","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.imbio.2022.152279_b1055","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b1060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","article-title":"Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells","volume":"32","author":"Pipkin","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2022.152279_b1065","doi-asserted-by":"crossref","first-page":"eaam6970","DOI":"10.1126\/sciimmunol.aam6970","article-title":"Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection","volume":"2","author":"Pizzolla","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.imbio.2022.152279_b1070","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1073\/pnas.76.4.1618","article-title":"Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro","volume":"76","author":"Plotch","year":"1979","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_b1075","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0092-8674(81)90449-9","article-title":"A unique cap(m7G pppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription","volume":"23","author":"Plotch","year":"1981","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_bib1719","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/cid\/cix869","article-title":"2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States","volume":"66","author":"Poehling","year":"2018","journal-title":"Clinical infectious diseases\u202f: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.imbio.2022.152279_b1080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0042-6822(69)90045-2","article-title":"Isolation and characterization of the ribonucleoprotein of influenza virus","volume":"39","author":"Pons","year":"1969","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_b1085","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1128\/JVI.73.4.3473-3476.1999","article-title":"Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template","volume":"73","author":"Poon","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b1090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/JVI.74.1.418-427.2000","article-title":"Polyuridylated mRNA Synthesized by a Recombinant Influenza Virus Is Defective in Nuclear Export","volume":"74","author":"Poon","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b1095","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2672.2001.01492.x","article-title":"A history of influenza","volume":"91","author":"Potter","year":"2001","journal-title":"J. Appl. Microbiol."},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_b1100","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.virol.2011.01.029","article-title":"The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding","volume":"412","author":"Qi","year":"2011","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1720","doi-asserted-by":"crossref","first-page":"e02281","DOI":"10.1128\/mBio.02281-16","article-title":"Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin","volume":"8","author":"Rajendran","year":"2017","journal-title":"mBio"},{"issue":"7","key":"10.1016\/j.imbio.2022.152279_bib1721","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"The Journal of infectious diseases"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_b1110","doi-asserted-by":"crossref","first-page":"e1006248","DOI":"10.1371\/journal.ppat.1006248","article-title":"Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection","volume":"13","author":"Rattan","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2022.152279_b1115","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1080\/21645515.2017.1313375","article-title":"A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control","volume":"13","author":"Ray","year":"2017","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1722","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1073\/pnas.1715471115","article-title":"Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody","volume":"115","author":"Raymond","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imbio.2022.152279_b1120","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1128\/jvi.71.11.8204-8212.1997","article-title":"Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice","volume":"71","author":"Reading","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b1125","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.4049\/jimmunol.180.5.3391","article-title":"Antiviral Activity of the Long Chain Pentraxin PTX3 against Influenza Viruses","volume":"180","author":"Reading","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_bib1723","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1465-9921-10-117","article-title":"Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice","volume":"10","author":"Reading","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.imbio.2022.152279_b1130","doi-asserted-by":"crossref","first-page":"e63852","DOI":"10.1371\/journal.pone.0063852","article-title":"The Influenza Virus Protein PB1-F2 Interacts with IKK\u03b2 and Modulates NF-\u03baB Signalling","volume":"8","author":"Reis","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018166","article-title":"An assessment of H1N1 influenza-associated acute respiratory distress syndrome severity after adjustment for treatment characteristics","volume":"6","author":"Riscili","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.imbio.2022.152279_b1135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/nar\/8.5.925","article-title":"Identification of the RNA region transferred from a representative primer, beta-globin mRNA, to influenza mRNA during in vitro transcription","volume":"8","author":"Robertson","year":"1980","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.imbio.2022.152279_bib1778","doi-asserted-by":"crossref","unstructured":"Rolfes, M. A., Flannery, B., Chung, J. R., O'Halloran, A., Garg, S., Belongia, E. A., Gaglani, M., Zimmerman, R. K., Jackson, M. L., Monto, A. S., Alden, N. B., Anderson, E., Bennett, N. M., Billing, L., Eckel, S., Kirley, P. D., Lynfield, R., Monroe, M. L., Spencer, M., Spina, N., \u2026 US Influenza Vaccine Effectiveness (Flu VE) Network, the Influenza Hospitalization Surveillance Network, and the Assessment Branch, Immunization Services Division, Centers for Disease Control and Prevention (2019). Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69(11), 1845\u20131853. https:\/\/doi.org\/10.1093\/cid\/ciz075.","DOI":"10.1093\/cid\/ciz075"},{"key":"10.1016\/j.imbio.2022.152279_b1140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","article-title":"Influenza virus assembly and budding","volume":"411","author":"Rossman","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.imbio.2022.152279_b1145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0042-6822(89)90248-1","article-title":"Electron microscopy of the influenza virus submembranal structure","volume":"173","author":"Ruigrok","year":"1989","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.imbio.2022.152279_bib1725","doi-asserted-by":"crossref","first-page":"e2074","DOI":"10.1002\/rmv.2074","article-title":"Inactivation methods for whole influenza vaccine production","volume":"29","author":"Sabbaghi","year":"2019","journal-title":"Reviews in medical virology"},{"key":"10.1016\/j.imbio.2022.152279_bib1726","doi-asserted-by":"crossref","unstructured":"Sagawa, H., Ohshima, A., Kato, I., Okuno, Y., & Isegawa, Y. (1996). The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region. The Journal of general virology, 77 ( Pt 7), 1483\u20131487. https:\/\/doi.org\/10.1099\/0022-1317-77-7-1483.","DOI":"10.1099\/0022-1317-77-7-1483"},{"key":"10.1016\/j.imbio.2022.152279_b1150","first-page":"153","article-title":"Influenza A: understanding the viral life cycle","volume":"82","author":"Samji","year":"2009","journal-title":"Yale Journal of Biology and Medicine"},{"issue":"9","key":"10.1016\/j.imbio.2022.152279_bib1727","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1128\/AAC.03313-14","article-title":"Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir","volume":"58","author":"Samson","year":"2014","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1728","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS medicine"},{"key":"10.1016\/j.imbio.2022.152279_b1155","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.4049\/jimmunol.2001287","article-title":"Influenza Virus and SARS-CoV-2 Vaccines","volume":"206","author":"Sandor","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_bib1729","doi-asserted-by":"crossref","unstructured":"Santos, N. B., Vaz da Silva, Z. E., Gomes, C., Reis, C. A., & Amorim, M. J. (2021). Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology. PLoS pathogens, 17(7), e1009381. https:\/\/doi.org\/10.1371\/journal.ppat.1009381.","DOI":"10.1371\/journal.ppat.1009381"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_b1160","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/jvi.68.5.3112-3119.1994","article-title":"Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia","volume":"68","author":"Sarawar","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b1165","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.4049\/jimmunol.160.12.6032","article-title":"Influenza A Virus-Induced IFN-\u03b1\/\u03b2 and IL-18 Synergistically Enhance IFN-\u03b3 Gene Expression in Human T Cells","volume":"160","author":"Sareneva","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114189","article-title":"Influenza-existing drugs and treatment prospects","volume":"232","author":"Sarker","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1730","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/vaccines8040574","article-title":"Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines","volume":"8","author":"Sayedahmed","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.imbio.2022.152279_b1175","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/JVI.79.10.6441-6448.2005","article-title":"Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection","volume":"79","author":"Schmitz","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1732","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.1218256109","article-title":"Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody","volume":"110","author":"Schmidt","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_bib1731","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2015.04.028","article-title":"Viral receptor-binding site antibodies with diverse germline origins","volume":"161","author":"Schmidt","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1733","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1073\/pnas.63.2.326","article-title":"Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus","volume":"63","author":"Schulman","year":"1969","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imbio.2022.152279_b1180","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature03326","article-title":"Toll-like receptor 3 promotes cross-priming to virus-infected cells","volume":"433","author":"Schulz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2022.152279_b1190","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JVI.76.3.1071-1076.2002","article-title":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells","volume":"76","author":"Seo","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b1195","first-page":"56","article-title":"Bacterial pneumonia: Managing a deadly complication of influenza in older adults with comorbid disease","volume":"57","author":"Sethi","year":"2002","journal-title":"Geriatrics"},{"key":"10.1016\/j.imbio.2022.152279_b1200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nsb0397-239","article-title":"Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1","volume":"4","author":"Sha","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.imbio.2022.152279_b1205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.apsb.2015.07.006","article-title":"New small-molecule drug design strategies for fighting resistant influenza A","volume":"5","author":"Shen","year":"2015","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1774","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2222\/jsv.56.85","volume":"56","author":"Shinya","year":"2006","journal-title":"Uirusu"},{"key":"10.1016\/j.imbio.2022.152279_b1210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-065X.2012.01124.x","article-title":"Germinal center selection and the development of memory B and plasma cells","volume":"247","author":"Shlomchik","year":"2012","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1735","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1473-3099(13)70286-X","article-title":"Pathogenesis of influenza-induced acute respiratory distress syndrome","volume":"14","author":"Short","year":"2014","journal-title":"The Lancet. Infectious diseases"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1736","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-2836(03)00761-7","article-title":"High-resolution structural insights into ligand binding and immune cell recognition by human lung surfactant protein D","volume":"331","author":"Shrive","year":"2003","journal-title":"Journal of molecular biology"},{"key":"10.1016\/j.imbio.2022.152279_b1215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.32607\/20758251-2009-1-2-26-32","article-title":"Influenza virus neuraminidase: structure and function","volume":"1","author":"Shtyrya","year":"2009","journal-title":"Acta naturae"},{"key":"10.1016\/j.imbio.2022.152279_b1220","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/eji.1830250442","article-title":"Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction","volume":"25","author":"Shu","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b1225","first-page":"1","article-title":"Viral entry","volume":"285","author":"Sieczkarski","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b1230","doi-asserted-by":"crossref","first-page":"12720","DOI":"10.1128\/JVI.01471-07","article-title":"Viral Encounters with 2',5'-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral Response","volume":"81","author":"Silverman","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b1235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bst0320021","article-title":"Proteases of the complement system","volume":"32","author":"Sim","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.imbio.2022.152279_b1240","doi-asserted-by":"crossref","unstructured":"Simonsen, L., Viboud, C., Taylor, R.J., Miller, M.A. 2011. The Epidemiology of Influenza and Its Control, Basel, 27 pp.","DOI":"10.1007\/978-3-0346-0279-2_2"},{"key":"10.1016\/j.imbio.2022.152279_b1245","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.imbio.2022.152279_b1250","first-page":"151","article-title":"The role of cytokines in the immune response to influenza A virus infection","volume":"50","author":"Sl\u00e1dkov\u00e1","year":"2006","journal-title":"Acta Virol."},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1737","first-page":"237","article-title":"An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus","volume":"43","author":"Smirnov","year":"1999","journal-title":"Acta virologica"},{"key":"10.1016\/j.imbio.2022.152279_bib1738","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current and next generation influenza vaccines: Formulation and production strategies","volume":"94","author":"Soema","year":"2015","journal-title":"European journal of pharmaceutics and biopharmaceutics\u202f: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.imbio.2022.152279_b1255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.intimp.2018.03.029","article-title":"C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury","volume":"59","author":"Song","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"6464","key":"10.1016\/j.imbio.2022.152279_bib1739","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.aay0678","article-title":"Broadly protective human antibodies that target the active site of influenza virus neuraminidase","volume":"366","author":"Stadlbauer","year":"2019","journal-title":"Science (New York, N.Y.)"},{"issue":"8","key":"10.1016\/j.imbio.2022.152279_b1260","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1034\/j.1600-0854.2000.010803.x","article-title":"Membrane fusion mechanisms: The influenza hemagglutinin paradigm and its implications for intracellular fusion","volume":"1","author":"Stegmann","year":"2000","journal-title":"Traffic"},{"key":"10.1016\/j.imbio.2022.152279_b1265","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI0215277","article-title":"Cytokines in innate host defense in the lung","volume":"109","author":"Strieter","year":"2002","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.imbio.2022.152279_b1270","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.183.2.693","article-title":"Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion","volume":"183","author":"Stuber","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2022.152279_bib1740","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vetmic.2016.11.025","article-title":"Recombinant viral-vectored vaccines for the control of avian influenza in poultry","volume":"206","author":"Suarez","year":"2017","journal-title":"Veterinary microbiology"},{"key":"10.1016\/j.imbio.2022.152279_b1275","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.imbio.2022.152279_b1280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1165\/rcmb.2012-0428OC","article-title":"Inhibition of Complement Activation Alleviates Acute Lung Injury Induced by Highly Pathogenic Avian Influenza H5N1 Virus Infection","volume":"49","author":"Sun","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.imbio.2022.152279_bib1741","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/v12091033","article-title":"Progress in the Development of Universal Influenza Vaccines","volume":"12","author":"Sun","year":"2020","journal-title":"Viruses"},{"issue":"45","key":"10.1016\/j.imbio.2022.152279_b1285","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1016\/j.vaccine.2010.08.074","article-title":"Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination","volume":"28","author":"Surls","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152279_b1290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4+ T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b1295","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_b1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104718","article-title":"Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017\u20132018","volume":"175","author":"Takashita","year":"2020","journal-title":"Antiviral Res."},{"issue":"6201","key":"10.1016\/j.imbio.2022.152279_bib1742","doi-asserted-by":"crossref","first-page":"1256070","DOI":"10.1126\/science.1256070","article-title":"Intracellular sensing of complement C3 activates cell autonomous immunity","volume":"345","author":"Tam","year":"2014","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.imbio.2022.152279_b1305","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/jir.1998.18.757","article-title":"Biochemical and genetic evidence for complex formation between the influenza a virus NS1 protein and the interferon-induced PKR protein kinase","volume":"18","author":"Tan","year":"1998","journal-title":"J. Interferon Cytokine Res."},{"issue":"23","key":"10.1016\/j.imbio.2022.152279_bib1779","doi-asserted-by":"crossref","first-page":"13580","DOI":"10.1128\/JVI.02289-14","article-title":"Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin","volume":"88","author":"Tan","year":"2014","journal-title":"Journal of virology"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_b1310","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01909-16","article-title":"The Short Form of the Zinc Finger Antiviral Protein Inhibits Influenza A Virus Protein Expression and Is Antagonized by the Virus-Encoded NS1","volume":"91","author":"Tang","year":"2017","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b1315","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virol.2011.01.036","article-title":"Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice","volume":"413","author":"Tate","year":"2011","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1743","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virol.2011.01.036","article-title":"Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice","volume":"413","author":"Tate","year":"2011","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1744","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/v6031294","article-title":"Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection","volume":"6","author":"Tate","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.imbio.2022.152279_b1320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 Influenza: The mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.imbio.2022.152279_b1325","first-page":"1793","article-title":"Initial Genetic Characterization of the 1918 & #x201c;Spanish\u201d","volume":"275","author":"Taubenberger","year":"1997","journal-title":"Influenza Virus. Science"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1745","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20071663","article-title":"Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus","volume":"412","author":"Tecle","year":"2008","journal-title":"The Biochemical journal"},{"issue":"24","key":"10.1016\/j.imbio.2022.152279_bib1746","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1128\/JVI.05193-11","article-title":"Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies","volume":"85","author":"Terajima","year":"2011","journal-title":"Journal of virology"},{"key":"10.1016\/j.imbio.2022.152279_b1335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/viro.1998.9384","article-title":"Phosphorylation of the M2 protein of influenza A virus is not essential for virus viability","volume":"252","author":"Thomas","year":"1998","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_b1330","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2009.02.006","article-title":"The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1","volume":"30","author":"Thomas","year":"2009","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.imbio.2022.152279_bib1747","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PloS one"},{"key":"10.1016\/j.imbio.2022.152279_bib1748","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1743-422X-8-50","article-title":"The pandemic (H1N1) 2009 influenza virus is resistant to mannose-binding lectin","volume":"8","author":"Tokunaga","year":"2011","journal-title":"Virology journal"},{"key":"10.1016\/j.imbio.2022.152279_b1340","doi-asserted-by":"crossref","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","article-title":"New world bats harbor diverse influenza A viruses","volume":"9","author":"Tong","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2022.152279_b1345","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMp038238","article-title":"Influenza Vaccine \u2014 Outmaneuvering Antigenic Shift and Drift","volume":"350","author":"Treanor","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.imbio.2022.152279_b1350","doi-asserted-by":"crossref","first-page":"14933","DOI":"10.1128\/JVI.79.23.14933-14944.2005","article-title":"Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice","volume":"79","author":"Tumpey","year":"2005","journal-title":"J. Virol."},{"issue":"5812","key":"10.1016\/j.imbio.2022.152279_bib1749","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1126\/science.1136212","article-title":"A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission","volume":"315","author":"Tumpey","year":"2007","journal-title":"Science (New York, N.Y.)"},{"issue":"32","key":"10.1016\/j.imbio.2022.152279_bib1750","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2022.152279_b1355","doi-asserted-by":"crossref","first-page":"e1002544","DOI":"10.1371\/journal.ppat.1002544","article-title":"Early Priming Minimizes the Age-Related Immune Compromise of CD8+ T Cell Diversity and Function","volume":"8","author":"Valkenburg","year":"2012","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.imbio.2022.152279_b1360","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/v4091438","article-title":"Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses","volume":"4","author":"van de Sandt","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.imbio.2022.152279_b1365","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/rmv.697","article-title":"Cell death-independent functions of granzymes: hit viruses where it hurts","volume":"21","author":"van Domselaar","year":"2011","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.imbio.2022.152279_bib1753","doi-asserted-by":"crossref","unstructured":"van Eijk, M., White, M. R., Crouch, E. C., Batenburg, J. J., Vaandrager, A. B., Van Golde, L. M., Haagsman, H. P., & Hartshorn, K. L. (2003). Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain. Journal of immunology (Baltimore, Md. : 1950), 171(3), 1431\u20131440. https:\/\/doi.org\/10.4049\/jimmunol.171.3.1431.","DOI":"10.4049\/jimmunol.171.3.1431"},{"issue":"6","key":"10.1016\/j.imbio.2022.152279_bib1643","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1165\/rcmb.2003-0355OC","article-title":"Interactions of influenza A virus with sialic acids present on porcine surfactant protein D","volume":"30","author":"van Eijk","year":"2004","journal-title":"American journal of respiratory cell and molecular biology"},{"issue":"23","key":"10.1016\/j.imbio.2022.152279_bib1751","doi-asserted-by":"crossref","first-page":"20137","DOI":"10.1074\/jbc.M111.224469","article-title":"Introduction of N-linked glycans in the lectin domain of surfactant protein D: impact on interactions with influenza A viruses","volume":"286","author":"van Eijk","year":"2011","journal-title":"The Journal of biological chemistry"},{"issue":"32","key":"10.1016\/j.imbio.2022.152279_bib1752","doi-asserted-by":"crossref","first-page":"26666","DOI":"10.1074\/jbc.M112.368571","article-title":"A unique sugar-binding site mediates the distinct anti-influenza activity of pig surfactant protein D","volume":"287","author":"van Eijk","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b1370","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.immuni.2011.04.020","article-title":"The Costimulatory Molecule CD27 Maintains Clonally Diverse CD8+ T Cell Responses of Low Antigen Affinity to Protect against Viral Variants","volume":"35","author":"van Gisbergen","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2022.152279_b1375","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.4049\/jimmunol.1200008","article-title":"The Bone Marrow Functions as the Central Site of Proliferation for Long-Lived NK Cells","volume":"189","author":"van Helden","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b1380","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-1135(00)00171-1","article-title":"Cytokines in the pathogenesis of influenza","volume":"74","author":"Van Reeth","year":"2000","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.imbio.2022.152279_b1385","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/303035a0","article-title":"Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 \u00c5 resolution","volume":"303","author":"Varghese","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2022.152279_b1390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.747654","article-title":"Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection","volume":"12","author":"Varghese","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b1395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585361","article-title":"C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus","volume":"11","author":"Varghese","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1755","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2007.070248","article-title":"Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals","volume":"171","author":"van Riel","year":"2007","journal-title":"The American journal of pathology"},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1754","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2353\/ajpath.2010.090949","article-title":"Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses","volume":"176","author":"van Riel","year":"2010","journal-title":"The American journal of pathology"},{"key":"10.1016\/j.imbio.2022.152279_b1400","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3390\/ijms23063045","article-title":"Human C1q Regulates Influenza A Virus Infection and Inflammatory Response via Its Globular Domain","volume":"23","author":"Varghese","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imbio.2022.152279_b1405","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.4049\/jimmunol.1103786","article-title":"Human H-Ficolin Inhibits Replication of Seasonal and Pandemic Influenza A Viruses","volume":"189","author":"Verma","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b1410","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1128\/JVI.00769-07","article-title":"N-Linked Glycosylation Attenuates H3N2 Influenza Viruses","volume":"81","author":"Vigerust","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b1415","doi-asserted-by":"crossref","first-page":"e1006685","DOI":"10.1371\/journal.ppat.1006685","article-title":"Fitness cost of reassortment in human influenza","volume":"13","author":"Villa","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2022.152279_b1420","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1134\/S0026893320020168","article-title":"Design of an Efficient Inhibitor for the Influenza A Virus M2 Ion Channel","volume":"54","author":"Vorobjev","year":"2020","journal-title":"Mol. Biol."},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_b1425","first-page":"832","article-title":"Detection of influenza C virus by using an in situ esterase assay","volume":"27","author":"Wagaman","year":"1989","journal-title":"Journal of Clinical"},{"issue":"16","key":"10.1016\/j.imbio.2022.152279_bib1756","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1128\/JVI.01203-13","article-title":"Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses","volume":"87","author":"Wan","year":"2013","journal-title":"Journal of virology"},{"key":"10.1016\/j.imbio.2022.152279_b1440","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/AAC.46.12.3809-3816.2002","article-title":"Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir","volume":"46","author":"Wang","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.imbio.2022.152279_b1435","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.chom.2007.06.009","article-title":"The Interferon-Inducible Protein Viperin Inhibits Influenza Virus Release by Perturbing Lipid Rafts","volume":"2","author":"Wang","year":"2007","journal-title":"Cell Host Microbe"},{"issue":"15","key":"10.1016\/j.imbio.2022.152279_b1430","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1128\/JVI.00126-14","article-title":"Influenza A Virus-Induced Degradation of Eukaryotic Translation Initiation Factor 4B Contributes to Viral Replication by Suppressing IFITM3 Protein Expression","volume":"88","author":"Wang","year":"2014","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_bib1757","doi-asserted-by":"crossref","first-page":"e02180","DOI":"10.1128\/mBio.02180-19","article-title":"Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines","volume":"10","author":"Wang","year":"2019","journal-title":"mBio"},{"issue":"31","key":"10.1016\/j.imbio.2022.152279_bib1759","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1016\/S0264-410X(03)00510-3","article-title":"Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin","volume":"21","author":"Watanabe","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_bib1758","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","article-title":"Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism","volume":"177","author":"Watanabe","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2022.152279_bib1760","doi-asserted-by":"crossref","unstructured":"Weaver, D. J., Jr, Reis, E. S., Pandey, M. K., K\u00f6hl, G., Harris, N., Gerard, C., & K\u00f6hl, J. (2010). C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. European journal of immunology, 40(3), 710\u2013721. https:\/\/doi.org\/10.1002\/eji.200939333.","DOI":"10.1002\/eji.200939333"},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_bib1761","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nature reviews. Drug discovery"},{"key":"10.1016\/j.imbio.2022.152279_b1445","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jama.2009.324","article-title":"The Evolution of Influenza Resistance and Treatment","volume":"301","author":"Weinstock","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.imbio.2022.152279_b1450","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1128\/JVI.00898-16","article-title":"Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening","volume":"90","author":"Weisshaar","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b1455","doi-asserted-by":"crossref","first-page":"L1293","DOI":"10.1152\/ajplung.00266.2007","article-title":"Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid","volume":"293","author":"White","year":"2007","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1762","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000272313","article-title":"Enhancement of antiviral activity of collectin trimers through cross-linking and mutagenesis of the carbohydrate recognition domain","volume":"2","author":"White","year":"2010","journal-title":"Journal of innate immunity"},{"key":"10.1016\/j.imbio.2022.152279_b1460","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1084\/jem.20041463","article-title":"Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection","volume":"201","author":"Whitmire","year":"2005","journal-title":"J Exp Med"},{"issue":"34","key":"10.1016\/j.imbio.2022.152279_bib1763","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imbio.2022.152279_b1465","series-title":"Pandemic Influenza Preparedness and Response: A WHO Guidance Document","author":"WHO","year":"2009"},{"key":"10.1016\/j.imbio.2022.152279_b1470","series-title":"Strengthening response to pandemics and other public-health emergencies\u202f: report of the Review Committee on the Functioning of the International Health Regulations (2005) and on Pandemic Influenza (H1N1) 2009","author":"WHO","year":"2011"},{"key":"10.1016\/j.imbio.2022.152279_b1475","series-title":"Up to 650 000 people die of respiratory diseases linked to seasonal flu each year","author":"WHO","year":"2017"},{"key":"10.1016\/j.imbio.2022.152279_b1480","article-title":"Influenza (Seasonal)","author":"WHO","year":"2018","journal-title":"World Health Orgainisation"},{"key":"10.1016\/j.imbio.2022.152279_b1495","series-title":"Recommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza season","author":"WHO","year":"2018"},{"key":"10.1016\/j.imbio.2022.152279_b1500","unstructured":"WHO. 2021. Recommended composition of influenza virus vaccines for use in the 2022 southern hemisphere influenza season, World Health Organisation."},{"key":"10.1016\/j.imbio.2022.152279_b1505","unstructured":"WHO. 2022. Recommendations announced for influenza vaccine composition for the 2022-2023 northern hemisphere influenza season, World Health Organisation."},{"key":"10.1016\/j.imbio.2022.152279_b1510","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","article-title":"Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation","volume":"289","author":"Wiley","year":"1981","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.imbio.2022.152279_b1515","doi-asserted-by":"crossref","first-page":"a038489","DOI":"10.1101\/cshperspect.a038489","article-title":"The Ecology and Evolution of Influenza Viruses","volume":"10","author":"Wille","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.imbio.2022.152279_b1520","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 \u00c5 resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.imbio.2022.152279_bib1764","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/JVI.02275-15","article-title":"Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice","volume":"90","author":"Wohlbold","year":"2015","journal-title":"Journal of virology"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1765","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/CMR.00097-12","article-title":"Traditional and new influenza vaccines","volume":"26","author":"Wong","year":"2013","journal-title":"Clinical microbiology reviews"},{"issue":"21","key":"10.1016\/j.imbio.2022.152279_bib1766","doi-asserted-by":"crossref","first-page":"e01154","DOI":"10.1128\/JVI.01154-19","article-title":"Modified Vaccinia Virus Ankara Can Induce Optimal CD8+ T Cell Responses to Directly Primed Antigens Depending on Vaccine Design","volume":"93","author":"Wong","year":"2019","journal-title":"Journal of virology"},{"key":"10.1016\/j.imbio.2022.152279_b1525","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","article-title":"Inhibiting the C5\u2013C5a receptor axis","volume":"48","author":"Woodruff","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_bib1767","doi-asserted-by":"crossref","unstructured":"Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista, E., Chotpitayasunondh, T., Gao, Z., Harper, S. A., Shaw, M., Uyeki, T. M., Zaki, S. R., Hayden, F. G., Hui, D. S., Kettner, J. D., Kumar, A., Lim, M., Shindo, N., Penn, C., & Nicholson, K. G. (2010). Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. The New England journal of medicine, 362(18), 1708\u20131719. https:\/\/doi.org\/10.1056\/NEJMra1000449.","DOI":"10.1056\/NEJMra1000449"},{"key":"10.1016\/j.imbio.2022.152279_b1535","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1189\/jlb.0313180","article-title":"Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection","volume":"95","author":"Wu","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imbio.2022.152279_bib1768","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1038\/ncomms8708","article-title":"A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus","volume":"6","author":"Wu","year":"2015","journal-title":"Nature communications"},{"issue":"5","key":"10.1016\/j.imbio.2022.152279_b1540","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/JVI.02749-15","article-title":"Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1","volume":"90","author":"Xia","year":"2016","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.imbio.2022.152279_b1545","doi-asserted-by":"crossref","first-page":"13053","DOI":"10.1128\/JVI.02220-13","article-title":"The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm","volume":"87","author":"Xiao","year":"2013","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_b1550","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0042-6822(88)90238-3","article-title":"Influenza B virus evolution: Co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses","volume":"163","author":"Yamashita","year":"1988","journal-title":"Virology"},{"issue":"5839","key":"10.1016\/j.imbio.2022.152279_bib1769","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.1135165","article-title":"Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity","volume":"317","author":"Yang","year":"2007","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.imbio.2022.152279_b1560","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/v5010352","article-title":"Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin","volume":"5","author":"Yang","year":"2013","journal-title":"Viruses"},{"issue":"51","key":"10.1016\/j.imbio.2022.152279_b1565","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1016\/j.vaccine.2010.09.081","article-title":"Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks","volume":"28","author":"Yao","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.imbio.2022.152279_bib1770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000350","article-title":"Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses","volume":"5","author":"Yoshida","year":"2009","journal-title":"PLoS pathogens"},{"key":"10.1016\/j.imbio.2022.152279_b1570","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2008.04.011","article-title":"Oseltamivir (Tamiflu\u00ae) increases dopamine levels in the rat medial prefrontal cortex","volume":"438","author":"Yoshino","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.imbio.2022.152279_b1575","article-title":"Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus","author":"Yuanji","year":"1983","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152279_bib1771","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1371\/journal.ppat.0010004","article-title":"Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1","volume":"1","author":"Zamarin","year":"2005","journal-title":"PLoS pathogens"},{"key":"10.1016\/j.imbio.2022.152279_b1585","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1128\/JVI.00415-06","article-title":"Influenza A Virus PB1-F2 Protein Contributes to Viral Pathogenesis in Mice","volume":"80","author":"Zamarin","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2022.152279_b1590","doi-asserted-by":"crossref","first-page":"22453","DOI":"10.1074\/jbc.M201632200","article-title":"Complementation of Pulmonary Abnormalities in SP-D Mice with an SP-D\/Conglutinin Fusion Protein.","volume":"277","author":"Zhang","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.imbio.2022.152279_bib1772","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.79.11.6644-6654.2005","article-title":"Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2","volume":"79","author":"Zharikova","year":"2005","journal-title":"Journal of virology"},{"key":"10.1016\/j.imbio.2022.152279_b1595","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of Effector CD4 T Cell Populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2022.152279_b1600","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/irv.12570","article-title":"65 years of influenza surveillance by a World Health Organization-coordinated global network","volume":"12","author":"Ziegler","year":"2018","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.imbio.2022.152279_b1605","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1128\/JVI.00712-11","article-title":"The viral nucleoprotein determines Mx sensitivity of influenza A viruses","volume":"85","author":"Zimmermann","year":"2011","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.imbio.2022.152279_b1610","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.168.4.1796","article-title":"Nasal-Associated Lymphoid Tissue Is a Mucosal Inductive Site for Virus-Specific Humoral and Cellular Immune Responses","volume":"168","author":"Zuercher","year":"2002","journal-title":"J Immunol"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852200105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852200105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:51:56Z","timestamp":1759251116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S017129852200105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":470,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S017129852200105X"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152279","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate and adaptive immune responses against Influenza A Virus: Immune evasion and vaccination strategies","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152279"}}